...
首页> 外文期刊>The Analyst: The Analytical Journal of the Royal Society of Chemistry: A Monthly International Publication Dealing with All Branches of Analytical Chemistry >Specific and sensitive detection of Plasmodium falciparum lactate dehydrogenase by DNA-scaffolded silver nanoclusters combined with an aptamer
【24h】

Specific and sensitive detection of Plasmodium falciparum lactate dehydrogenase by DNA-scaffolded silver nanoclusters combined with an aptamer

机译:DNA支架银纳米蛋白酶组合适体的DNA-支架银纳米蛋白酶乳酸脱氢酶的具体和敏感性检测

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Innovative nanomaterials offer significant potential for diagnosis of severe diseases of the developing world such as malaria. Small sized silver nanoclusters have shown promise for diagnostics due to their intense fluorescence emission and photo-stabilities. Here, double-stranded DNA-scaffolded silver nanoclusters (AgNCs-dsDNA) were prepared to detect the established malaria biomarker, Plasmodium falciparum lactate dehydrogenase (PfLDH). Significant luminescence enhancement over a wide concentration range of PfLDH was demonstrated. In addition, a low limit of detection at 0.20 nM (7.4 pg mu L-1) was achieved for PfLDH in buffer solution, sensitive enough for practical use correlating with the clinical level of PfLDH in plasma from malaria-infected patients. Unique specificity was observed towards Plasmodium falciparum over Plasmodium vivax and human lactate dehydrogenase, as well as other non-specific proteins, by combining the use of AgNCs-dsDNA with a DNA aptamer against PfLDH. Moreover, the intrinsic mechanism was revealed in detail for the two-step luminescence response. The combination of DNA-scaffolded silver nanoclusters coupled to a selective single-stranded DNA aptamer allows for a highly specific and sensitive detection of PfLDH with significant promise for malaria diagnosis in future.
机译:创新的纳米材料具有诊断疟疾中发展世界严重疾病的巨大潜力。由于它们强烈的荧光发射和光稳定性,小型银纳米能器已经显示了诊断的承诺。这里,制备双链DNA-支架银纳米蛋白(AgNCS-DSDNA)以检测已建立的疟疾生物标志物,疟原虫乳酸脱氢酶(PFLDH)。证明了在广泛浓度范围内的PFLDH的显着发光提高。另外,在缓冲溶液中对PFLDH的PFLDH实现了低于0.20nm(7.4pg mu L-1)的低限制,足够敏感,用于实际使用与来自疟疾感染患者的血浆中PFLDH的临床水平相关。通过将AgNCS-DSDNA与抗PFLDH的DNA适体的使用AgNCS-DSDNA与DNA适体相结合,对疟原虫和人乳酸脱氢酶以及其他非特异性蛋白质观察到独特的特异性。此外,对两步发光反应的详细揭示了本征机制。与选择性单链DNA适体偶联的DNA-支架银纳米团簇的组合允许对PFLDH的高度特异性和敏感的检测,并在未来的疟疾诊断具有显着的希望。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号